• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行期间的经导管主动脉瓣植入术

Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic.

作者信息

Valdebenito Martín, Massalha Eias, Barbash Israel M, Maor Elad, Fefer Paul, Guetta Victor, Segev Amit

机构信息

Interventional Cardiology Unit, Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Interventional Cardiology Unit, Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel.

出版信息

Am J Cardiol. 2021 Apr 15;145:97-101. doi: 10.1016/j.amjcard.2020.12.086. Epub 2021 Jan 15.

DOI:10.1016/j.amjcard.2020.12.086
PMID:33454341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836376/
Abstract

Transcatheter aortic valve implantation (TAVI) outcomes during the coronavirus disease 2019 (COVID-19) pandemic have not been fully evaluated and some structural programs in the world have been suspended during this period. We sought to evaluate and compare clinical outcomes in patients undergoing TAVI in pandemic versus nonpandemic era. In a single center, we compared 198 TAVI patients performed during 2019 to 59 patients performed during the COVID-19 pandemic period (March 1st to June 30th, 2020). Primary outcome was procedural success according to VARC criteria and 30-day mortality rates. VARC-defined procedural success was high in both groups (93.3% vs 96.6%; p = 0.53). There were no differences in any vascular complications (26% vs 19%; p = 0.3), permanent pacemaker implantation (11.8% vs 15.3%; p = 0.63), and length of hospital stay (5.2 vs 4.2 days; p = 0.29). Thirty-day mortality was similar (3% vs 3.4%; p = 1.0). We had no documented COVID-19 disease in our patients during follow up. In conclusion, TAVI procedures can be performed effectively and safely during the COVID-9 pandemic, using a minimalist approach, early discharge, and by maintaining proper use of personal protective equipment.

摘要

经导管主动脉瓣植入术(TAVI)在2019冠状病毒病(COVID-19)大流行期间的结果尚未得到充分评估,在此期间,世界上一些结构性项目已暂停。我们试图评估和比较在大流行时期与非大流行时期接受TAVI治疗的患者的临床结果。在一个单一中心,我们比较了2019年期间进行的198例TAVI患者与COVID-19大流行期间(2020年3月1日至6月30日)进行的59例患者。主要结局是根据瓣膜学术研究联盟(VARC)标准的手术成功率和30天死亡率。两组中VARC定义的手术成功率都很高(93.3%对96.6%;p = 0.53)。在任何血管并发症(26%对19%;p = 0.3)、永久性起搏器植入(11.8%对15.3%;p = 0.63)和住院时间(5.2天对4.2天;p = 0.29)方面没有差异。30天死亡率相似(3%对3.4%;p = 1.0)。在随访期间,我们的患者中没有记录到COVID-19疾病。总之,在COVID-19大流行期间,可以采用极简主义方法、早期出院并保持正确使用个人防护设备,有效地、安全地进行TAVI手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6977/7836376/a7b922b3ef5a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6977/7836376/a7b922b3ef5a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6977/7836376/a7b922b3ef5a/gr1_lrg.jpg

相似文献

1
Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic.2019冠状病毒病大流行期间的经导管主动脉瓣植入术
Am J Cardiol. 2021 Apr 15;145:97-101. doi: 10.1016/j.amjcard.2020.12.086. Epub 2021 Jan 15.
2
Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.在 COVID-19 时代,行简化经导管主动脉瓣置换术且术后无并发症患者的当日出院安全性。
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):940-947. doi: 10.1002/ccd.29453. Epub 2020 Dec 31.
3
Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload.经新冠疫情期间行经导管主动脉瓣植入术:一种优化模型以缓解医疗系统过载。
Int J Cardiol. 2022 Apr 1;352:190-194. doi: 10.1016/j.ijcard.2022.01.038. Epub 2022 Jan 22.
4
Factors associated with safe early discharge after transcatheter aortic valve implantation.经导管主动脉瓣植入术后安全早期出院的相关因素。
Cardiol J. 2018;25(1):14-23. doi: 10.5603/CJ.a2017.0087. Epub 2017 Jul 17.
5
Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.经导管主动脉瓣植入术(TAVI)的极简方法:开放血管法与完全经皮法
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):5-14. doi: 10.2478/prilozi-2019-0009.
6
Transcatheter aortic valve replacement during the COVID-19 pandemic-A Dutch single-center analysis.COVID-19大流行期间的经导管主动脉瓣置换术——一项荷兰单中心分析
J Card Surg. 2021 Jan;36(1):48-55. doi: 10.1111/jocs.15123. Epub 2020 Oct 21.
7
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation.2019年冠状病毒病大流行对经导管主动脉瓣植入术的时机和早期临床结局的影响
Acta Cardiol. 2022 Dec;77(10):937-942. doi: 10.1080/00015385.2022.2119660. Epub 2022 Oct 5.
8
Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.经导管主动脉瓣植入术后与外科主动脉瓣置换术后高度房室传导阻滞的起搏特点及当前起搏实践模式比较
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E385-E390. doi: 10.1002/ccd.27915. Epub 2018 Oct 9.
9
Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.单中心队列中经导管主动脉瓣植入术采用最新一代Sapien 3瓣膜与Direct Flow Medical瓣膜的比较。
Int J Cardiol. 2017 Apr 1;232:186-191. doi: 10.1016/j.ijcard.2017.01.032. Epub 2017 Jan 7.
10
Comparison of Efficacy and Safety of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Versus Tricuspid Aortic Valves.二叶式与三叶式主动脉瓣患者经导管主动脉瓣植入术的疗效和安全性比较
Am J Cardiol. 2017 Nov 1;120(9):1601-1606. doi: 10.1016/j.amjcard.2017.07.053. Epub 2017 Jul 31.

引用本文的文献

1
A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.经导管主动脉瓣植入术的简化途径:BENCHMARK 研究。
Eur Heart J. 2024 Jun 1;45(21):1904-1916. doi: 10.1093/eurheartj/ehae147.
2
National Trends of Structural Heart Disease Interventions from 2016 to 2020 in the United States and the Associated Impact of COVID-19 Pandemic.美国 2016 年至 2020 年结构性心脏病介入治疗的国家趋势及 COVID-19 大流行的相关影响。
Curr Probl Cardiol. 2023 Mar;48(3):101526. doi: 10.1016/j.cpcardiol.2022.101526. Epub 2022 Nov 28.
3
Changes to transcatheter aortic valve replacement (TAVR) services during the first wave of the COVID-19 pandemic: A single centre experience from United Kingdom tertiary hospital.
新冠疫情期间经导管主动脉瓣置换术(TAVR)服务的变化:来自英国三级医院的单中心经验。
Hellenic J Cardiol. 2022 Sep-Oct;67:36-41. doi: 10.1016/j.hjc.2022.07.001. Epub 2022 Jul 4.
4
Structured Allocation of Transcatheter Aortic Valve Replacement Patients during Coronavirus Disease 2019 Pandemic: Impact on Patient Selection and Clinical Results.2019年冠状病毒病大流行期间经导管主动脉瓣置换术患者的结构化分配:对患者选择和临床结果的影响
J Cardiovasc Dev Dis. 2022 Jun 10;9(6):189. doi: 10.3390/jcdd9060189.
5
Transcatheter aortic valve implantation amid the COVID-19 pandemic: a nationwide analysis of the first COVID-19 wave in the Netherlands.2019冠状病毒病大流行期间的经导管主动脉瓣植入术:荷兰首次2019冠状病毒病浪潮的全国性分析
Neth Heart J. 2022 Nov;30(11):503-509. doi: 10.1007/s12471-022-01704-9. Epub 2022 Jun 1.
6
Stress-testing interventional cardiology organization to streamline procedures during COVID-19 pandemic, and beyond.对介入心脏病学组织进行压力测试,以在新冠疫情期间及之后简化流程。
Int J Cardiol. 2022 May 1;354:84-85. doi: 10.1016/j.ijcard.2022.02.032. Epub 2022 Feb 27.
7
Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload.经新冠疫情期间行经导管主动脉瓣植入术:一种优化模型以缓解医疗系统过载。
Int J Cardiol. 2022 Apr 1;352:190-194. doi: 10.1016/j.ijcard.2022.01.038. Epub 2022 Jan 22.
8
Cardiac Care of Non-COVID-19 Patients During the SARS-CoV-2 Pandemic: The Pivotal Role of CCTA.2019冠状病毒病大流行期间非2019冠状病毒病患者的心脏护理:CT血管造影的关键作用
Front Cardiovasc Med. 2021 Nov 24;8:775115. doi: 10.3389/fcvm.2021.775115. eCollection 2021.